Paper36136557
Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches.
Kępczyńska K and 1 other. Toxins (Basel), 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches. Papers, record 36136557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36136557
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Migraine Disorders | Major topic |
| Neuromuscular Agents | Major topic |
| Tension-Type Headache | Major topic |
| Calcitonin Gene-Related Peptide | |
| Glutamates | |
| Headache | |
| Humans | |
| Quality of Life | |
| SNARE Proteins | |
| Substance P | |
| Treatment Outcome |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17547312 | Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. | Aviat Space Environ Med | 2007 | https://conductscience.org/library/papers/17547312 | PubMed |
| 2 | 12011271 | Diagnostic lessons from the spectrum study. | Neurology | 2002 | https://conductscience.org/library/papers/12011271 | PubMed |
| 3 | 26232105 | Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache. | Cephalalgia | 2016 | https://conductscience.org/library/papers/26232105 | PubMed |
| 4 | 15836567 | Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. | Headache | 2005 | https://conductscience.org/library/papers/15836567 | PubMed |
| 5 | 34090319 | The efficacy of botulinum toxin A treatment for tension-type or cervicogenic headache: a systematic review and meta-analysis of randomized, placebo-controlled trials. | Scand J Pain | 2021 | https://conductscience.org/library/papers/34090319 | PubMed |
| 6 | 33008506 | OnabotulinumtoxinA injection in the treatment of chronic migraine. | Prog Brain Res | 2020 | https://conductscience.org/library/papers/33008506 | PubMed |
| 7 | 30522135 | Migraine and Tension-Type Headache. | Semin Neurol | 2018 | https://conductscience.org/library/papers/30522135 | PubMed |
| 8 | 35906722 | Temporomandibular disorders and neck pain in primary headache patients: a retrospective machine learning study. | Acta Odontol Scand | 2023 | https://conductscience.org/library/papers/35906722 | PubMed |
| 9 | 33348571 | Botulinum Toxin in the Treatment of Headache. | Toxins (Basel) | 2020 | https://conductscience.org/library/papers/33348571 | PubMed |
| 10 | 24915026 | Botulinum toxin A, brain and pain. | Prog Neurobiol | 2014 | https://conductscience.org/library/papers/24915026 | PubMed |
| 11 | 24819339 | Therapeutic use of botulinum toxin in migraine: mechanisms of action. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24819339 | PubMed |
| 12 | 22275844 | Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine. | Neuropsychiatr Dis Treat | 2012 | https://conductscience.org/library/papers/22275844 | PubMed |
| 13 | 33726534 | The Secondary Headaches. | Cephalalgia | 2021 | https://conductscience.org/library/papers/33726534 | PubMed |
| 14 | 29368949 | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. | Cephalalgia | 2018 | https://conductscience.org/library/papers/29368949 | PubMed |
| 15 | 27844455 | GBD 2015: migraine is the third cause of disability in under 50s. | J Headache Pain | 2016 | https://conductscience.org/library/papers/27844455 | PubMed |
| 16 | 31563224 | Migraine: Epidemiology, Burden, and Comorbidity. | Neurol Clin | 2019 | https://conductscience.org/library/papers/31563224 | PubMed |
| 17 | 20647171 | OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. | Cephalalgia | 2010 | https://conductscience.org/library/papers/20647171 | PubMed |
| 18 | 22535858 | Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. | JAMA | 2012 | https://conductscience.org/library/papers/22535858 | PubMed |
| 19 | 17040331 | Modifiable risk factors for migraine progression. | Headache | 2006 | https://conductscience.org/library/papers/17040331 | PubMed |
| 20 | 29493566 | Cluster headache. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29493566 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42784323 | Adjunctive Use of Botulinum Toxin in Orthognathic Surgery: A Systematic Review of Current Evidence and Clinical Perspectives. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42784323 | PubMed |
| 42784282 | One Molecule, Different Circuits? What Botulinum Toxin Can and Cannot Reveal About Craniocervical Comorbidity. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42784282 | PubMed |
| 42347502 | Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42347502 | PubMed |
| 41709680 | Post-Botulinum Headache in Cosmetic Practice: A Prospective Study. | J Cosmet Dermatol | 2026 | https://conductscience.org/library/papers/41709680 | PubMed |
| 41682889 | Neurochemical Changes Following Botulinum Toxin Type A in Chronic Migraine: An LC-MS/MS and HPLC Evaluation of Plasma and Urinary Biomarkers. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682889 | PubMed |
| 41607435 | Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. | World J Psychiatry | 2026 | https://conductscience.org/library/papers/41607435 | PubMed |
| 40142828 | Botulinum Toxin Therapy: A Comprehensive Review on Clinical and Pharmacological Insights. | J Clin Med | 2025 | https://conductscience.org/library/papers/40142828 | PubMed |
| 39984566 | Intradermally injected abobotulinumtoxinA administered preemptively before surgery alleviates post-surgical pain and normalizes behavior in a translational animal model. | Sci Rep | 2025 | https://conductscience.org/library/papers/39984566 | PubMed |
| 39453207 | Non-Migraine Head Pain and Botulinum Toxin. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39453207 | PubMed |
| 39227336 | Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims Data. | J Clin Neurol | 2024 | https://conductscience.org/library/papers/39227336 | PubMed |
| 38962481 | The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session. | Front Neurol | 2024 | https://conductscience.org/library/papers/38962481 | PubMed |
| 38839615 | Evaluation of the Effect of Botulinum Toxin A on the Lymphatic Endothelial Cells. | Aesthetic Plast Surg | 2024 | https://conductscience.org/library/papers/38839615 | PubMed |
| 38672000 | Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort. | Brain Sci | 2024 | https://conductscience.org/library/papers/38672000 | PubMed |
| 37235358 | Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/37235358 | PubMed |
| 37090974 | Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study. | Front Neurol | 2023 | https://conductscience.org/library/papers/37090974 | PubMed |
| 36983822 | Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36983822 | PubMed |
| 36828401 | A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/36828401 | PubMed |
| 36668895 | Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/36668895 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TAC1 | 6863 | PubTator's text mining | https://conductscience.org/library/genes/6863 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36136557
GET https://conductscience.org/api/papers/v1/36136557/references?page=2